Pardali K, Kurisaki A, Morén A, ten Dijke P, Kardassis D, Moustakas A
Ludwig Institute for Cancer Research, Box 595, SE-751 24 Uppsala, Sweden.
J Biol Chem. 2000 Sep 22;275(38):29244-56. doi: 10.1074/jbc.M909467199.
Transforming growth factor-beta (TGF-beta) inhibits cell cycle progression, in part through up-regulation of gene expression of the p21(WAF1/Cip1) (p21) cell cycle inhibitor. Previously we have reported that the intracellular effectors of TGF-beta, Smad3 and Smad4, functionally cooperate with Sp1 to activate the human p21 promoter in hepatoma HepG2 cells. In this study we show that Smad3 and Smad4 when overexpressed in HaCaT keratinocytes lead to activation of the p21 promoter. Activation requires the binding sites for the ubiquitous transcription factor Sp1 on the proximal promoter. Induction of the endogenous HaCaT p21 gene by TGF-beta1 is further enhanced after overexpression of Smad3 and Smad4, whereas dominant negative mutants of Smad3 and Smad4 and the inhibitory Smad7 all inhibit p21 induction by TGF-beta1 in a dose-dependent manner. We show that Sp1 expressed in the Sp1-deficient Drosophila SL-2 cells binds to the proximal p21 promoter sequences, whereas Smad proteins do not. In support of this finding, we show that DNA-binding domain mutants of Smad3 and Smad4 are capable of transactivating the p21 promoter as efficiently as wild type Smads. Co-expression of Smad3 with Smad4 and Sp1 in SL-2 cells or co-incubation of phosphorylated Smad3, Smad4, and Sp1 in vitro results in enhanced binding of Sp1 to the p21 proximal promoter sequences. We demonstrate that Sp1 physically and directly interacts with Smad2, Smad3, and weakly with Smad4 via their amino-terminal (Mad-Homology 1) domain. Finally, by using GAL4 fusion proteins we show that the glutamine-rich sequences in the transactivation domain of Sp1 contribute to the cooperativity with Smad proteins. In conclusion, Smad proteins play important roles in regulation of the p21 gene by TGF-beta, and the functional cooperation of Smad proteins with Sp1 involves the physical interaction of these two types of transcription factors.
转化生长因子-β(TGF-β)可抑制细胞周期进程,部分原因是通过上调p21(WAF1/Cip1)(p21)细胞周期抑制剂的基因表达来实现的。此前我们曾报道,TGF-β的细胞内效应分子Smad3和Smad4在肝癌HepG2细胞中与Sp1在功能上协同作用,以激活人p21启动子。在本研究中,我们发现当Smad3和Smad4在HaCaT角质形成细胞中过表达时,可导致p21启动子的激活。激活需要近端启动子上普遍存在的转录因子Sp1的结合位点。在Smad3和Smad4过表达后,TGF-β1对内源性HaCaT p21基因的诱导作用进一步增强,而Smad3和Smad4的显性负性突变体以及抑制性Smad7均以剂量依赖的方式抑制TGF-β1对p21的诱导。我们发现,在缺乏Sp1的果蝇SL-2细胞中表达的Sp1可与近端p21启动子序列结合,而Smad蛋白则不能。为支持这一发现,我们表明Smad3和Smad4的DNA结合结构域突变体能够与野生型Smad一样有效地反式激活p21启动子。在SL-2细胞中Smad3与Smad4和Sp1共表达,或在体外将磷酸化的Smad3、Smad4和Sp1共同孵育,均可增强Sp1与p21近端启动子序列的结合。我们证明,Sp1通过其氨基末端(Mad-同源性1)结构域与Smad2、Smad3发生物理性直接相互作用,并与Smad4发生较弱的相互作用。最后,通过使用GAL4融合蛋白,我们表明Sp1反式激活结构域中的富含谷氨酰胺序列有助于与Smad蛋白的协同作用。总之,Smad蛋白在TGF-β对p21基因的调控中发挥重要作用,Smad蛋白与Sp1的功能协同作用涉及这两种转录因子的物理相互作用。